DK1981906T3 - Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse - Google Patents

Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse

Info

Publication number
DK1981906T3
DK1981906T3 DK07712110.1T DK07712110T DK1981906T3 DK 1981906 T3 DK1981906 T3 DK 1981906T3 DK 07712110 T DK07712110 T DK 07712110T DK 1981906 T3 DK1981906 T3 DK 1981906T3
Authority
DK
Denmark
Prior art keywords
peptides
sevi
promotion
viral infection
human sperm
Prior art date
Application number
DK07712110.1T
Other languages
English (en)
Inventor
Jan Muench
Ludger Staendker
Wolf-Georg Forssmann
Knut Adermann
Frank Kirchhoff
Elke Ruecker
Original Assignee
Viro Pharmaceuticals Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viro Pharmaceuticals Gmbh & Co Kg filed Critical Viro Pharmaceuticals Gmbh & Co Kg
Application granted granted Critical
Publication of DK1981906T3 publication Critical patent/DK1981906T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK07712110.1T 2006-01-25 2007-01-25 Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse DK1981906T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100818 2006-01-25
PCT/EP2007/050727 WO2007085630A1 (en) 2006-01-25 2007-01-25 Human semen enhancer of viral infection peptides (sevi) and their use

Publications (1)

Publication Number Publication Date
DK1981906T3 true DK1981906T3 (da) 2011-01-10

Family

ID=36423519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07712110.1T DK1981906T3 (da) 2006-01-25 2007-01-25 Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse

Country Status (7)

Country Link
US (1) US8299031B2 (da)
EP (1) EP1981906B1 (da)
JP (1) JP2009524420A (da)
AT (1) ATE461216T1 (da)
DE (1) DE602007005354D1 (da)
DK (1) DK1981906T3 (da)
WO (1) WO2007085630A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071024A1 (en) * 2007-12-14 2009-06-17 Pharis Biotec GmbH Peptides of human prostatic acid phosphatase enhancing viral infectivity
JP6175055B2 (ja) * 2011-06-30 2017-08-02 ジェネトン ウイルス感染増強特性を有するペプチドおよびその使用
SG11201404361UA (en) 2012-01-26 2014-09-26 Life Technologies Corp Methods for increasing the infectivity of viruses
WO2022004707A1 (ja) * 2020-06-30 2022-01-06 国立大学法人大阪大学 ＳＡＲＳ－ＣｏＶ－２吸着担体およびそれを含むカラム
EP4067375A1 (en) * 2021-03-30 2022-10-05 Universität Ulm Fibril peptides
CN115708506B (zh) * 2022-11-14 2024-01-26 海南大学 一种马氏珠母贝精子低温保存方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
CA2425648A1 (en) * 2000-10-19 2002-04-19 Epimmune Inc. Hla class i and ii binding peptides and their uses
GB0406054D0 (en) 2004-03-17 2004-04-21 Univ Nottingham Trent Prostatic acid phosphatase antigens

Also Published As

Publication number Publication date
HK1125386A1 (en) 2009-08-07
US20090191206A1 (en) 2009-07-30
EP1981906B1 (en) 2010-03-17
ATE461216T1 (de) 2010-04-15
JP2009524420A (ja) 2009-07-02
US8299031B2 (en) 2012-10-30
WO2007085630A1 (en) 2007-08-02
EP1981906A1 (en) 2008-10-22
DE602007005354D1 (de) 2010-04-29

Similar Documents

Publication Publication Date Title
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
EA201200277A1 (ru) Антитела против респираторного синцитиального вируса (pcb) и способы их применения
EA201291243A1 (ru) Антитела против респираторно-синцитиального вируса (рсв) и способы их применения
EA201300125A1 (ru) Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии
NO20076021L (no) Antistoffer rettet mot amyloid-betapeptid og metoder som anvender de samme
CY1118994T1 (el) Πρωτεϊνες συνδεσης αντιγονου il-17 υποδοχεα α
NO20054608L (no) Influensavirusvaksine
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
JP2009537143A5 (da)
WO2009044273A3 (en) Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
EA201600476A1 (ru) Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение
EP2043622A4 (en) CANCER TREATMENT USING PROTEIN KINASE MODULATION BASED ON BETA
ATE543804T1 (de) Neue verbindungen
EA201170353A1 (ru) Антитела против гепатита с и их применение
DE69922261D1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
ATE554789T1 (de) Neues hundeinfluenza-virus und imfpstoff hierfür
ATE461216T1 (de) Humaner verstärker der viralen infektion (sevi) und seine anwendung
CY1114724T1 (el) Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων
EA200601219A1 (ru) Новые конденсированные пирролокарбазолы
DK2025750T3 (da) Targets og forbindelser til terapeutisk intervention af HIV-infektion
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
AR060797A1 (es) Composicion farmaceutica que comprende la proteina nmb0606
AR060796A1 (es) Composicion farmaceutica que comprende la proteina nmb0938